Alaunos Therapeutics Statistics
Total Valuation
TCRT has a market cap or net worth of $17.45 million. The enterprise value is $13.31 million.
Market Cap | 17.45M |
Enterprise Value | 13.31M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, before market open.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TCRT has 16.01 million shares outstanding. The number of shares has increased by 0.21% in one year.
Shares Outstanding | 16.01M |
Shares Change (YoY) | +0.21% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 14.30% |
Owned by Institutions (%) | 14.61% |
Float | 13.08M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3,490.73 |
Forward PS | n/a |
PB Ratio | 3.64 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2,661.73 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.87, with zero debt.
Current Ratio | 4.87 |
Quick Ratio | 3.34 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -24.07 |
Financial Efficiency
Return on equity (ROE) is -229.60% and return on invested capital (ROIC) is -549.05%.
Return on Equity (ROE) | -229.60% |
Return on Assets (ROA) | -173.70% |
Return on Capital (ROIC) | -549.05% |
Revenue Per Employee | $5,000 |
Profits Per Employee | -$26.77M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.43% in the last 52 weeks. The beta is -0.26, so TCRT's price volatility has been lower than the market average.
Beta (1Y) | -0.26 |
52-Week Price Change | -85.43% |
50-Day Moving Average | 1.39 |
200-Day Moving Average | 1.60 |
Relative Strength Index (RSI) | 39.12 |
Average Volume (30 Days) | 51,711 |
Short Selling Information
The latest short interest is 1.45 million, so 9.07% of the outstanding shares have been sold short.
Short Interest | 1.45M |
Short Previous Month | 1.47M |
Short % of Shares Out | 9.07% |
Short % of Float | 11.10% |
Short Ratio (days to cover) | 28.42 |
Income Statement
In the last 12 months, TCRT had revenue of $5,000 and -$26.77 million in losses. Loss per share was -$1.86.
Revenue | 5,000 |
Gross Profit | 5,000 |
Operating Income | -26.34M |
Pretax Income | -26.77M |
Net Income | -26.77M |
EBITDA | -23.91M |
EBIT | -25.71M |
Loss Per Share | -$1.86 |
Balance Sheet
The company has $4.15 million in cash and no debt, giving a net cash position of $4.15 million or $0.26 per share.
Cash & Cash Equivalents | 4.15M |
Total Debt | n/a |
Net Cash | 4.15M |
Net Cash Per Share | $0.26 |
Equity / Book Value | 4.80M |
Book Value Per Share | 0.30 |
Working Capital | 4.80M |
Cash Flow
In the last 12 months, operating cash flow was -$22.68 million and capital expenditures $1.37 million, giving a free cash flow of -$21.31 million.
Operating Cash Flow | -22.68M |
Capital Expenditures | 1.37M |
Free Cash Flow | -21.31M |
FCF Per Share | -$1.33 |
Margins
Gross margin is 100.00%, with operating and profit margins of -526,760.00% and -535,480.00%.
Gross Margin | 100.00% |
Operating Margin | -526,760.00% |
Pretax Margin | -535,480.00% |
Profit Margin | -535,480.00% |
EBITDA Margin | -478,240.00% |
EBIT Margin | -514,120.00% |
FCF Margin | -426,180.00% |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.21% |
Shareholder Yield | -0.21% |
Earnings Yield | -153.40% |
FCF Yield | -122.09% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 1, 2024. It was a reverse split with a ratio of 1:15.
Last Split Date | Feb 1, 2024 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
TCRT has an Altman Z-Score of -217.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -217.41 |
Piotroski F-Score | 2 |